Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Amyopathic dermatomyositis].

Katalin Dankó1, Enikö Simkovics, Orsolya Nagymáté

  • 1Debreceni Egyetem Orvos- és Egészségtudományi Centrum, III. sz. Belgyógyászati Klinika. danko@iiibel.dote.hu

Orvosi Hetilap
|March 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B-type natriuretic peptide attenuates TLR-induced cytokine and chemokine secretion in monocyte-derived Langerhans cells.

Frontiers in immunology·2026
Same author

Proposition for a New Classification of Hypersensitivity Reactions - an Expanded Nomenclature.

Clinical reviews in allergy & immunology·2026
Same author

Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Development of Nomograms to Predict the Probability of Recurrence at Specific Sites in Patients with Cutaneous Melanoma.

Cancers·2025
Same author

Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype.

Frontiers in immunology·2025

Amyopathic dermatomyositis is a rare autoimmune condition where skin symptoms appear before muscle involvement. This review summarizes recent findings on managing this specific form of dermatomyositis.

Area of Science:

  • Rheumatology
  • Dermatology
  • Immunology

Context:

  • Dermatomyositis is a rare idiopathic inflammatory myopathy.
  • Amyopathic dermatomyositis (ADM) is a subtype characterized by skin manifestations preceding or occurring without significant muscle involvement.
  • The distinction between ADM and other dermatomyositis forms is crucial for treatment decisions.

Purpose:

  • To review and synthesize the latest research findings on amyopathic dermatomyositis.
  • To clarify diagnostic criteria and management strategies for ADM.
  • To discuss the implications of recent advancements for patient care.

Summary:

  • ADM presents with characteristic skin findings of dermatomyositis but minimal or absent myositis.
  • The diagnosis relies on specific cutaneous signs and exclusion of significant muscle disease.

Related Experiment Videos

  • Current research focuses on differentiating ADM from clinically amyopathic dermatomyositis and guiding therapeutic interventions, balancing potential benefits against treatment side effects.

    • Impact:

    • Provides clinicians with an updated understanding of ADM.
    • Aids in differentiating ADM, informing treatment decisions between systemic and local therapies.
    • Highlights the importance of ongoing research in managing this rare autoimmune condition.